Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике. Евразийские клинические рекомендации. 2016 год
Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике. Евразийские клинические рекомендации. 2016 год
Сидоренко С.В., Яковлев С.В., Спичак Т.В. и др. Стратегия и тактика рационального применения антимикробных средств в амбулаторной практике. Евразийские клинические рекомендации. Педиатрия (Прил. к журн. Consilium Medicum). 2017; 1: 17–25.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
26. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995; 273: 214–9.
27. Ball P, Baquero F, Cars O et al. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence.
J Antimicrob Chemother 2002; 49 (1): 31–40.
28. Schlemmer B. Impact of registration procedures on antibiotic polices. Clin Microbiol Infect Dis 2001; 7 (Suppl. 6): 5–8.
29. Gonzales R, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001; 134 (6): 479–86.
30. Snow V, Gonzales R. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med 2001; 134 (6): 487–9.
31. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infection, and bronchitis by ambulatory care physicians. JAMA 1997; 278: 901–4.
32. Hickner JM, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 134 (6): 498–505.
33. Williams JW, Aguilar C, Makela M et al. Antibiotic therapy for acute sinusitis: a systematic literature review. In: R.Douglas, C.Bridges-Webb, eds. Acute Respiratory Infections Module of the Cochrane Database of Systematic reviews. The cochrane Library. Oxford: Updated Software, 1997.
34. Zucher DR, Balk E, Engels E et al. Diagnosos and treatment of acute bacterial rhinosinusitis. Agency for Health Care Policy and Research Publication No. 99–E016. Evidence Report/Technology Assessment Number 9. www.ahrq.gov/clinic/sinusitis.htm.
35. Guo D, Cai Y, Chai D et al. The cardiotoxicity of macrolides: a systematic review. Pharmazie 2010; 65 (9): 631–40.
36. Ray WA, Murray KT, Hall K et al. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012; 366 (20): 1881–90.
37. Paterson JM, Mamdani MM, Manno M et al. Fluoroquinolone therapy and idiosyncratic liver injuri: a population-based study. CMAJ 2012; 184 (14): 1565–70.
38. Low DE. Antimicrobial drug use and resistance among respiratory pathogens in the community. Clin Infect Dis 2001; 33 (Suppl. 3): S206–13.
39. Guillemot D. How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach. Clin Microbiol Infect 2001; 7 (Suppl. 5): 19–23.
40. Kristinsson KG et al. Microb Drug Resist 1997; 3: 117–23.
41. Baquero F. Microb Drug Resist 1995; 1: 115–20.
42. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994; 13: 1075–8.
43. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441–6.
27. Ball P, Baquero F, Cars O et al. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence.
J Antimicrob Chemother 2002; 49 (1): 31–40.
28. Schlemmer B. Impact of registration procedures on antibiotic polices. Clin Microbiol Infect Dis 2001; 7 (Suppl. 6): 5–8.
29. Gonzales R, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001; 134 (6): 479–86.
30. Snow V, Gonzales R. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med 2001; 134 (6): 487–9.
31. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infection, and bronchitis by ambulatory care physicians. JAMA 1997; 278: 901–4.
32. Hickner JM, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 134 (6): 498–505.
33. Williams JW, Aguilar C, Makela M et al. Antibiotic therapy for acute sinusitis: a systematic literature review. In: R.Douglas, C.Bridges-Webb, eds. Acute Respiratory Infections Module of the Cochrane Database of Systematic reviews. The cochrane Library. Oxford: Updated Software, 1997.
34. Zucher DR, Balk E, Engels E et al. Diagnosos and treatment of acute bacterial rhinosinusitis. Agency for Health Care Policy and Research Publication No. 99–E016. Evidence Report/Technology Assessment Number 9. www.ahrq.gov/clinic/sinusitis.htm.
35. Guo D, Cai Y, Chai D et al. The cardiotoxicity of macrolides: a systematic review. Pharmazie 2010; 65 (9): 631–40.
36. Ray WA, Murray KT, Hall K et al. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012; 366 (20): 1881–90.
37. Paterson JM, Mamdani MM, Manno M et al. Fluoroquinolone therapy and idiosyncratic liver injuri: a population-based study. CMAJ 2012; 184 (14): 1565–70.
38. Low DE. Antimicrobial drug use and resistance among respiratory pathogens in the community. Clin Infect Dis 2001; 33 (Suppl. 3): S206–13.
39. Guillemot D. How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach. Clin Microbiol Infect 2001; 7 (Suppl. 5): 19–23.
40. Kristinsson KG et al. Microb Drug Resist 1997; 3: 117–23.
41. Baquero F. Microb Drug Resist 1995; 1: 115–20.
42. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994; 13: 1075–8.
43. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441–6.
27. Ball P, Baquero F, Cars O et al. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence.
J Antimicrob Chemother 2002; 49 (1): 31–40.
28. Schlemmer B. Impact of registration procedures on antibiotic polices. Clin Microbiol Infect Dis 2001; 7 (Suppl. 6): 5–8.
29. Gonzales R, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001; 134 (6): 479–86.
30. Snow V, Gonzales R. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med 2001; 134 (6): 487–9.
31. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infection, and bronchitis by ambulatory care physicians. JAMA 1997; 278: 901–4.
32. Hickner JM, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 134 (6): 498–505.
33. Williams JW, Aguilar C, Makela M et al. Antibiotic therapy for acute sinusitis: a systematic literature review. In: R.Douglas, C.Bridges-Webb, eds. Acute Respiratory Infections Module of the Cochrane Database of Systematic reviews. The cochrane Library. Oxford: Updated Software, 1997.
34. Zucher DR, Balk E, Engels E et al. Diagnosos and treatment of acute bacterial rhinosinusitis. Agency for Health Care Policy and Research Publication No. 99–E016. Evidence Report/Technology Assessment Number 9. www.ahrq.gov/clinic/sinusitis.htm.
35. Guo D, Cai Y, Chai D et al. The cardiotoxicity of macrolides: a systematic review. Pharmazie 2010; 65 (9): 631–40.
36. Ray WA, Murray KT, Hall K et al. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012; 366 (20): 1881–90.
37. Paterson JM, Mamdani MM, Manno M et al. Fluoroquinolone therapy and idiosyncratic liver injuri: a population-based study. CMAJ 2012; 184 (14): 1565–70.
38. Low DE. Antimicrobial drug use and resistance among respiratory pathogens in the community. Clin Infect Dis 2001; 33 (Suppl. 3): S206–13.
39. Guillemot D. How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach. Clin Microbiol Infect 2001; 7 (Suppl. 5): 19–23.
40. Kristinsson KG et al. Microb Drug Resist 1997; 3: 117–23.
41. Baquero F. Microb Drug Resist 1995; 1: 115–20.
42. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994; 13: 1075–8.
43. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441–6.
________________________________________________
27. Ball P, Baquero F, Cars O et al. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence.
J Antimicrob Chemother 2002; 49 (1): 31–40.
28. Schlemmer B. Impact of registration procedures on antibiotic polices. Clin Microbiol Infect Dis 2001; 7 (Suppl. 6): 5–8.
29. Gonzales R, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001; 134 (6): 479–86.
30. Snow V, Gonzales R. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med 2001; 134 (6): 487–9.
31. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infection, and bronchitis by ambulatory care physicians. JAMA 1997; 278: 901–4.
32. Hickner JM, Bartlett JG, Besser RE et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 134 (6): 498–505.
33. Williams JW, Aguilar C, Makela M et al. Antibiotic therapy for acute sinusitis: a systematic literature review. In: R.Douglas, C.Bridges-Webb, eds. Acute Respiratory Infections Module of the Cochrane Database of Systematic reviews. The cochrane Library. Oxford: Updated Software, 1997.
34. Zucher DR, Balk E, Engels E et al. Diagnosos and treatment of acute bacterial rhinosinusitis. Agency for Health Care Policy and Research Publication No. 99–E016. Evidence Report/Technology Assessment Number 9. www.ahrq.gov/clinic/sinusitis.htm.
35. Guo D, Cai Y, Chai D et al. The cardiotoxicity of macrolides: a systematic review. Pharmazie 2010; 65 (9): 631–40.
36. Ray WA, Murray KT, Hall K et al. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012; 366 (20): 1881–90.
37. Paterson JM, Mamdani MM, Manno M et al. Fluoroquinolone therapy and idiosyncratic liver injuri: a population-based study. CMAJ 2012; 184 (14): 1565–70.
38. Low DE. Antimicrobial drug use and resistance among respiratory pathogens in the community. Clin Infect Dis 2001; 33 (Suppl. 3): S206–13.
39. Guillemot D. How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach. Clin Microbiol Infect 2001; 7 (Suppl. 5): 19–23.
40. Kristinsson KG et al. Microb Drug Resist 1997; 3: 117–23.
41. Baquero F. Microb Drug Resist 1995; 1: 115–20.
42. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994; 13: 1075–8.
43. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441–6.
Авторы
С.В.Яковлев1, Е.В.Елисеева2, М.П.Суворова1, И.А.Дронов1, С.В.Сидоренко3,4, В.В.Рафальский5,6, И.Н.Захарова7, А.Л.Заплатников7, Т.В.Спичак1, В.К.Таточенко8, Н.А.Геппе1, А.Б.Малахов1, М.В.Журавлева1, Б.С.Белов9, А.В.Гуров10
1 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М.Сеченова» Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2;
2 ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Минздрава России. 690002, Владивосток, пр-т Острякова, д. 2;
3 ФГБУ «Научно-исследовательский институт детских инфекций» ФМБА России. 197022, Россия, Санкт-Петербург, ул. Профессора Попова, д. 9;
4 ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И.Мечникова» Минздрава России. 191015, Россия, Санкт-Петербург, ул. Кирочная, д. 41;
5 АНО «Институт клинической фармакологии». 214000, Россия, Смоленск, ул. Ново-Киевская, д. 9;
6 ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России. 214019, Россия, Смоленск, ул. Крупской, д. 28;
7 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 125993, Россия, Москва, ул. Баррикадная, д. 2/1;
8 ФГАУ «Научный центр здоровья детей» Минздрава России. 119991, Россия, Москва, Ломоносовский пр-т, д. 2, стр. 1;
9 ФГБНУ «Научно-исследовательский институт ревматологии им. В.А.Насоновой». 115522, Россия, Москва, Каширское ш., д. 34А;
10 ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1
1 I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2;
2 Pacific State Medical University Ministry of Health of the Russian Federation. 690002, Russian Federation, Vladivostok, pr-t Ostriakova, d. 2;
3 Research Institute of Children's Infections. 197022, Russian Federation, Saint Petersburg, ul. Professora Popova, d. 9;
4 I.I.Mechnikov State Northwestern Medical University of the Ministry of Health of the Russian Federation. 191015, Russian Federation, Saint Petersburg, ul. Kirochnaia, d. 41;
5 Institute of Clinical Pharmacology. 214000, Russian Federation, Smolensk, ul. Novo-Kievskaya, d. 9;
6 Smolensk State Medical University of the Ministry of Health of the Russian Federation. 214019, Russian Federation, Smolensk, ul. Krupskoi, d. 28;
7 Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1;
8 Scientific Center of Children Health of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, Lomonosovskii pr-t, d. 2, str. 1;
9 V.A.Nasonova Research Institute of Rheumatology. 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34A;
10 N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
1 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М.Сеченова» Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2;
2 ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Минздрава России. 690002, Владивосток, пр-т Острякова, д. 2;
3 ФГБУ «Научно-исследовательский институт детских инфекций» ФМБА России. 197022, Россия, Санкт-Петербург, ул. Профессора Попова, д. 9;
4 ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И.Мечникова» Минздрава России. 191015, Россия, Санкт-Петербург, ул. Кирочная, д. 41;
5 АНО «Институт клинической фармакологии». 214000, Россия, Смоленск, ул. Ново-Киевская, д. 9;
6 ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России. 214019, Россия, Смоленск, ул. Крупской, д. 28;
7 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России. 125993, Россия, Москва, ул. Баррикадная, д. 2/1;
8 ФГАУ «Научный центр здоровья детей» Минздрава России. 119991, Россия, Москва, Ломоносовский пр-т, д. 2, стр. 1;
9 ФГБНУ «Научно-исследовательский институт ревматологии им. В.А.Насоновой». 115522, Россия, Москва, Каширское ш., д. 34А;
10 ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1
________________________________________________
1 I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2;
2 Pacific State Medical University Ministry of Health of the Russian Federation. 690002, Russian Federation, Vladivostok, pr-t Ostriakova, d. 2;
3 Research Institute of Children's Infections. 197022, Russian Federation, Saint Petersburg, ul. Professora Popova, d. 9;
4 I.I.Mechnikov State Northwestern Medical University of the Ministry of Health of the Russian Federation. 191015, Russian Federation, Saint Petersburg, ul. Kirochnaia, d. 41;
5 Institute of Clinical Pharmacology. 214000, Russian Federation, Smolensk, ul. Novo-Kievskaya, d. 9;
6 Smolensk State Medical University of the Ministry of Health of the Russian Federation. 214019, Russian Federation, Smolensk, ul. Krupskoi, d. 28;
7 Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation. 125993, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1;
8 Scientific Center of Children Health of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, Lomonosovskii pr-t, d. 2, str. 1;
9 V.A.Nasonova Research Institute of Rheumatology. 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34A;
10 N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.